Morgan Stanley has announced a new offering of market-linked securities linked to NVIDIA Corporation's common stock. This comes as part of the firm’s strategy to enhance its product offerings in the competitive securities brokerage sector.
The free writing prospectus, filed on November 12, 2026, outlines the terms of the securities, which are set to offer contingent coupon payments and a memory feature. This innovative approach allows investors to receive payments based on the performance of NVIDIA's stock, which is a significant player in the technology sector.
Background
Morgan Stanley, a leading global financial services firm, operates under the Standard Industrial Classification (SIC) code 6211, which pertains to Security Brokers, Dealers & Flotation Companies. The company is publicly traded on the New York Stock Exchange under the ticker symbol MS, among others.
In recent filings, Morgan Stanley has been active, with multiple Schedule 13G and 13G/A forms filed on November 13, 2026, indicating ongoing corporate activities and shareholder changes.
What the Filing Says
The filing provides details about the structured investments being offered, specifically noting that they are “Market Linked Securities—Auto-Callable with Contingent Coupon with Memory Feature and Contingent Downside.” These securities are designed to be fully and unconditionally guaranteed by Morgan Stanley, providing a layer of security for investors.
Key features include a contingent coupon rate of at least 11.25% per annum, contingent upon the stock’s performance, and a maturity date set for November 23, 2029. The prospectus outlines that if certain conditions are met, investors may receive their principal investment back along with any applicable coupon payments.
Impact
This new offering may attract a variety of investors looking for innovative financial products that provide both risk and potential reward. It reflects Morgan Stanley's strategy to cater to diverse investor needs while navigating a competitive landscape filled with other major firms in the securities brokerage sector.
What’s Next
Further details about the offering, including specific pricing and investor participation, are expected as the pricing date approaches on November 17, 2026. The filing does not specify what happens next beyond this date.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










